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Integrin cooperation with growth factor receptors to
enable permissive signaling to the mitogen-activated
protein (MAP) kinase pathway has important implica-
tions for cell proliferation, differentiation, and survival.
Here we have sought to determine whether anchorage
regulation of the MAP kinase pathway is specific to the
a chain subunit of the integrins employed during adhe-
sion. Human umbilical vein endothelial cells (HUVECs)
anchored via endogenous a2, a3, or a5 integrin subunits
or NIH3T3 fibroblast cells lines anchored via ectopically
expressed human integrin a2 or a5 subunits displayed
comparable MAP kinase activation upon growth factor
stimulation, regardless of the integrin a chain em-
ployed. In contrast, when either cell type was main-
tained in suspension, growth factor treatment ineffi-
ciently activated the MAP kinase pathway. The integrin-
mediated enhancement of MAP kinase activation by
growth factor correlated with the tyrosine phosphoryl-
ation of focal adhesion kinase but was independent of
Shc. These data indicate that integrin modulation of the
MAP kinase pathway is supported by a variety of inte-
grin complexes and imply that other pathways may be
required for the previously reported a chain-specific
effects on cell cycle regulation and cell differentiation.
The regulation of many cellular events is dependent upon the
coordinated effects of cues from adhesive interactions with the
extracellular matrix and the presence of circulating growth
factors. For example, the anchorage dependence of cell growth
has been recognized for many years, and anchorage is also a
necessary component of differentiation and survival in many
cell types. Recent studies have suggested that adhesion via
integrin receptors is able to control growth factor signaling
pathways and that this regulation may play a key role in
adhesion-dependent cellular responses. Specifically, findings in
fibroblasts have indicated that upon growth factor stimulation,
cells adherent to the extracellular matrix component fibronec-
tin show enhanced activation of the p42 and p44 forms of MAP1
kinase (1–4). Similar observations have been made in endothe-
lial cells, whether cells are stimulated by agonists to receptor
tyrosine kinases or G-protein-coupled receptors (5). In addition
to this collaborative signaling, engagement of integrin recep-
tors in the absence of growth factor causes a direct transient
activation of MAP kinases (6–8).
In collaborative signaling, the point of convergence where
integrin signals merge with the growth factor pathway appears
to be different depending on the cells and the conditions used.
Adhesion-mediated control has been found at the level of re-
ceptor tyrosine phosphorylation (2, 9) and at the activation of
Raf (1) or MAP kinase/extracellular signal-regulated protein
kinase (3). Integrin regulation of the MAP kinase pathway may
provide insight into the mechanism of anchorage-dependent
effects on cell cycle progression (10). Upon activation, MAP
kinases can translocate to the nucleus and regulate the activity
of several transcription factors. These events ultimately im-
pinge on the expression of cyclin-dependent kinases and their
regulatory subunits, cyclins (11, 12). Anchorage is clearly a
necessary component in the regulation of cyclin-dependent ki-
nases, their associated cyclins, and cyclin-dependent kinase
inhibitor proteins during the G1 phase of the cell cycle (13–16).
To date the specific involvement of integrin receptors in
adhesion-dependent growth factor signaling to MAP kinases
has been addressed either by using function blocking antibod-
ies to the b1 subunit to promote signaling or by showing inef-
ficient signaling when cells are attached by nonspecific inter-
actions to a polylysine-coated surface. However, the integrin
subunit specificity of this effect remains unexplored. Several
studies have shown important roles for the a chain of the
integrin heterodimer in the regulation of differentiation,
growth control, and apoptosis. For example, the decision of
myoblasts to follow either a proliferative or differentiation
pathway can be controlled by expression of a chains; exogenous
expression of a5 promotes cell proliferation, whereas expres-
sion of a6 promotes differentiation (17). The proliferative mech-
anism is transmitted through increases in the cellular levels of
the b1 subunit leading to enhanced MAP kinase activity and is
also influenced by changes in the levels of tyrosine-phosphory-
lated focal adhesion proteins (18). In HUVECs and fibroblasts,
a role and interesting mechanism for integrin a subunits in
growth control has recently been proposed (19). HUVECs
plated on fibronectin or vitronectin entered the S phase of the
cell cycle in response to growth factors, whereas a low percent-
age of cells plated on laminin entered S phase, despite cell
spreading (19). Since a5b1, avb3, and a2b1 are the principal
receptors responsible for binding to fibronectin, vitronectin,
and laminin, respectively, these data suggest that progression
through G1 is integrin a chain-specific. These findings correlate
with direct signaling via integrins to MAP kinases; the inte-
grins thought to be involved in this process are a5b1, avb3, and
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a1b1 but not a2b1, a3b1, or a6b1 (19). In this model, the trans-
membrane protein caveolin serves as a link between certain
integrins and the Src family kinase, Fyn, which in turn phos-
phorylates the adaptor molecule, Shc, to initiate the MAP ki-
nase cascade (19, 20). Direct-mediated activation of MAP ki-
nase via caveolin and Shc was found to be independent of FAK
tyrosine phosphorylation (19), in agreement with our observa-
tion using a different experimental strategy (21). A further
example of a chain specificity in controlling cellular responses
is found in studies on extracellular matrix control of mammary
epithelial cells. Signals mediated through a6 but not a2 inte-
grins collaborate with insulin-dependent signals to suppress
apoptosis in these cells (22).
It has been suggested that direct integrin-specific activation
of the MAP kinase cascade via caveolin and Shc may contribute
to cell cycle progression (19, 20). By contrast, other studies
have shown that activation of MAP kinases per se is not suffi-
cient to permit cell cycle progression. Thus, constitutive acti-
vation of MAP kinase in suspended lung fibroblast cells by
expression of an activable form of Raf does not lead to increased
expression of cyclin D1 (23). Additionally, endothelial cells
partially spread on low concentrations of fibronectin are
blocked in the G1 phase of the cell cycle despite being able to
respond to growth factors by activating MAP kinases (24).
Evidently, there are several unresolved issues in the rela-
tionship between integrins, MAP kinase, and cell cycle control.
We sought to investigate one of these issues, the involvement of
specific a subunits in integrin collaboration with growth factors
in the signaling to MAP kinases. Cells were attached via dif-
ferent a chains and were analyzed for the ability of epidermal
growth factor (EGF) to activate MAP kinases. We observed that
a2b1, a3b1, and a5b1 integrins permitted efficient signaling to
MAP kinases. These findings point toward the existence of
integrin-specific events, other than control of growth factor
signaling to MAP kinases, that are important in integrin ef-
fects on the cell cycle. Additionally, the ability of cells to re-
spond to growth factor correlated with the tyrosine phospho-
rylation of FAK but was independent of Shc. Thus, the
mechanisms of two forms of integrin-mediated signals, direct
and collaborative signaling to MAP kinase, show important
differences.
EXPERIMENTAL PROCEDURES
Constructs—Human a5 cDNA, subcloned from pECEa5 (25) into the
NotI and XbaI sites of pcDNA3.1 (Invitrogen, Carlsbad, CA), was pro-
vided by J.-W. Lee (Department of Pharmacology, University of North
Carolina). Human a2 cDNA in the pSFneo vector was a gift from Dr. M.
Hemler (26).
Antibodies—Anti-human integrin antibodies, P1E6 and P1D6 (Life
Technologies, Inc.), were used to select cells expressing human a2 and
a5, respectively. Anti-a3 antibody, P1B6, was used in cell attachment
experiments. An anti-a2 cytoplasmic domain polyclonal antibody (27)
and a monoclonal anti-human a5 (Transduction Laboratories, Lexing-
ton, KY) were used for Western analysis. Anti-phosphotyrosine clone
4G10 and anti-FAK clone 2A7 were purchased from Upstate Biotech-
nologies Inc. (Lake Placid, NY) and anti-FAK, clone 77, was from
Transduction Laboratories. Shc was immunoprecipitated from cells
with a polyclonal antibody (S1630) and visualized by Western blotting
with a monoclonal antibody (S14620), both from Transduction
Laboratories.
Cell Selection and Culture—HUVECs were obtained from Clonetics
(San Diego, CA) and maintained according to the supplier’s directions.
Cells were used between passages 2 and 3. NIH3T3 cells were trans-
fected using SuperFect (Qiagen Inc., Valencia, CA) with vectors ex-
pressing human a2 or human a5 subunits. Transfected cells were se-
lected by capturing with magnetic beads (Dynal Inc., Lake Success, NY)
bound with species-specific antibodies (21). Cells underwent three
rounds of antibody-mediated selection. NIH3T3 cells lines were main-
tained in Dulbecco’s minimal essential medium (DMEM) containing
10% bovine calf serum and 500 mM G418.
Flow Cytometry—Cells (5 3 106) were detached using trypsin/EDTA
and resuspended in PBS, 0.1% BSA for 45 min on ice, followed by
washing in PBS, 0.1% BSA. Secondary antibody incubations using
anti-mouse IgG coupled to phycoerythrin (Sigma) were carried out for
45 min on ice. After further washing, cells were fixed in 2% formalde-
hyde in PBS and analyzed for fluorescence using a Becton Dickinson
(Bedford, MA) flow cytometer.
Preparation of Ligand-coated Dishes or Flasks—Anti-mouse IgG-
precoated MicroCellector flasks (Applied Immune Science, Santa Clara,
CA) were incubated with anti-integrin antibodies (P1D6, P1E6, or P1B6
at 2 ml/ml) at 4 °C overnight. Tissue culture dishes were incubated with
20 mg/ml human fibronectin (Collaborative Biomedical Products, Bed-
ford, MA) at 4 °C overnight. The coated flasks and dishes were blocked
with 2% BSA in DMEM for 1 h at room temperature prior to use.
Cell Adherence and Preparation of Cell Lysate—For experiments,
confluent cells were serum-starved for 4–6 h before detachment by
trypsin/EDTA; trypsin activity was subsequently neutralized with 1
mg/ml soybean trypsin inhibitor (Life Technologies, Inc.). Cells were
suspended in DMEM with 2% BSA (NIH3T3) or endothelial cell basal
medium, 2% BSA (HUVECs) and incubated nonadherently at 37 °C for
45 min in a rotator to allow kinases to become quiescent. Cells were
then plated onto antibody- or fibronectin-coated dishes or maintained in
suspension and incubated at 37 °C for the indicated times. Following
incubations, cells were washed twice with cold PBS and then lysed in a
modified RIPA buffer (6). Total cell lysates were cleared by centrifuga-
tion at 16,000 3 g for 5 min at 4 °C. Protein concentration in the lysates
was determined using the bicinchoninic acid assay (Pierce).
Immunoprecipitation and Western Blotting—For immunoprecipita-
tion, cell lysates were first incubated with antibody for 2 h at 4 °C,
followed by the addition of protein G-Sepharose and then further incu-
bated for 2 h at 4 °C. Precipitates were washed 3 times with cold RIPA
buffer and boiled with SDS-PAGE sample buffer to dissociate the pro-
teins. For analysis by Western blotting, samples were separated by
SDS-PAGE under reducing conditions. The proteins were transferred
electrophoretically onto polyvinylidene fluoride membranes (Immobilon
P, Millipore Corp., Bedford, MA). The membranes were blocked with 1%
BSA and 0.1% Tween 20 in PBS overnight at 4 °C and subsequently
incubated with primary antibody (1 mg/ml) in PBS containing 1% BSA
and 0.1% Tween 20 for 1 h at room temperature. Active MAP kinase
was detected using an antibody purchased from Promega (Madison,
WI), and total levels of MAP kinase were detected using Sc-94 antibody
(Santa Cruz Biotechnology, Santa Cruz, CA). The membranes were
washed in PBS, 0.1% Tween and incubated with goat anti-mouse IgG or
goat anti-rabbit IgG peroxidase conjugates (Calbiochem) for 1 h. Immu-
noreactivity was detected on Hyperfilm using enhanced chemilumines-
cence (Amersham Pharmacia Biotech). Bands from Western blots were
quantified using a GS-670 model densitometer (Bio-Rad).
In Vitro Kinase Reactions—p42 MAP kinase was immunoprecipi-
tated for in vitro kinase assays using the C-14 antibody (Santa Cruz
Biotechnology). Immunoprecipitates were washed three times with cold
washing buffer (0.25 M Tris, pH 7.5, 0.1 M NaCl). Immunoprecipitates
were resuspended in 40 ml of kinase assay buffer containing 10 mM Tris,
pH 7.5, 10 mM MgCl2, 1 mM dithiothreitol, 10 mM ATP, 5 mCi of
[g-32P]ATP (370 MBq/ml; NEN Life Science Products), and 10 mg of
myelin basic protein (Upstate Biotechnology Inc.). Following a 30-min
incubation at room temperature, reactions were terminated upon the
addition of SDS-PAGE sample buffer and by boiling for 3 min. The
samples were subjected to SDS-PAGE, and dried gels were visualized
using a Storm 840 PhosphorImager with Image-QuaNT software (Mo-
lecular Dynamics, Sunnyvale, CA).
RESULTS
Recent studies have proposed a role for the a chains of
integrin receptors in the ability of cells to activate directly the
p42 and p44 MAP kinases, permit cell cycle progression, and
avoid apoptosis upon adhesion (19, 20). However, direct inte-
grin-mediated activation of MAP kinases is insufficient for cells
to proceed through the cell cycle (19, 29), and the significance of
integrin-mitogen collaboration for cell proliferation is still un-
clear. To explore these issues further, we investigated whether
anchorage-modulated signaling to MAP kinases via receptor
tyrosine kinases shows integrin a chain specificity.
First, we analyzed the effect of cell anchorage via different
integrin a chains in HUVECs. We have previously shown that
in HUVECs, EGF signaling to MAP kinases is anchorage-de-
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pendent and that the expression levels of the a2 and a5 sub-
units are very similar (5). To examine the integrin specificity of
signaling, serum-starved HUVECs were either maintained in
suspension or allowed to adhere to fibronectin, to an anti-a5
antibody (P1D6), or to an anti-a2 antibody (P1E6), before stim-
ulation with EGF. Antibody-mediated attachment of HUVECs
was ligand-specific; thus an irrelevant, anti-KT3 epitope tag
mouse antibody did not allow attachment. HUVECs attached
and spread on the antibody-coated plates almost to the same
extent as cells adhering to fibronectin. Western blotting with
an antibody that recognizes active forms of p42 and p44 MAP
kinases showed that EGF efficiently activated MAP kinases in
cells attached via both a2 and a5 integrins, but poorly activated
MAP kinases in cells maintained in suspension (Fig. 1A). Im-
portantly, the efficiency of signaling on antibody-coated sur-
faces was similar to that of cells plated on fibronectin (Fig. 1A).
These findings were confirmed by the use of in vitro MAP
kinase assays using myelin basic protein as substrate (Fig. 1B).
In addition, cells attached via the a3 subunit also support
efficient EGF signaling to MAP kinases (Fig. 1C). These find-
ings indicate that adhesion-dependent growth factor signaling
is not specific to particular a chains in HUVECs.
To examine further the effects of adhesion via different in-
tegrin a chains on signaling, NIH3T3 cell lines stably express-
ing either human a2 (Hua2-NIH3T3) or a5 integrins (Hua5-
NIH3T3) were established. Expression of these subunits was
confirmed by immunoprecipitation studies using human-spe-
cific antibodies (Fig. 2A). Flow cytometry analysis demon-
strated cell surface expression of the appropriate human inte-
grin a subunit in the Hua2-NIH3T3 and Hua5-NIH3T3 lines;
the expression level in Hua2-NIH3T3 was slightly higher than
in Hua5-NIH3T3 (Fig. 2B). Furthermore, these lines adhered
specifically to dishes coated with antibodies that recognized the
expressed human integrin subunit and not to plates coated
with antibodies to the alternative subunit. These data indicate
that the exogenously expressed integrin a subunits pair with
endogenous b subunits and are expressed on the cell surface.
We analyzed integrin-growth factor collaboration upon en-
gagement of different integrins in these NIH3T3 cell lines.
Consistent with published findings in wild-type NIH3T3 cells
(1, 4), when cells were maintained in suspension or plated on
fibronectin and stimulated with EGF, the Hua2-NIH3T3 and
Hua5-NIH3T3 lines displayed anchorage-dependent signaling
to MAP kinases (Figs. 3, A and B). Both the Hua2-NIH3T3 and
Hua5-NIH3T3 lines adhered rapidly but spread poorly when
cells were anchored appropriately via either anti-a2 or anti-a5
antibody. EGF-mediated activation of MAP kinases was equiv-
alently increased in both cell lines plated on the antibody-
coated surfaces, above the level of activation in suspension. In
both cell lines, the signaling on the antibody-coated surfaces
was not as strong as signaling on a fibronectin-coated surfaces,
likely representing a lesser degree of cortical actin cytoskeletal
structure (4). Levels of active MAP kinase were quantified from
four separate experiments and normalized for levels of total
FIG. 1. Adhesion of HUVECS via different a integrin subunits
supports efficient EGF signaling to MAP kinases. Serum-starved
HUVECs were detached and incubated non-adherently for 45 min at
37 °C. Cells were allowed to adhere to fibronectin (Fn) or antibody (a2,
a3, or a5)-coated plates, or maintained in suspension (Sus) for 2 h in
serum-free conditions before treatment with 10 ng/ml EGF for 5 min.
Cells were lysed in modified RIPA buffer and analyzed by Western
blotting (WB) with antibodies to active MAP kinases and total levels of
MAP kinases (A and C) or MAP kinase was immunoprecipitated (IP)
and activity measured by an in vitro kinase assay using myelin basic
protein (MBP) as substrate (B). Results from experiments using a2 and
a5 antibodies were consistent in four separate experiments.
FIG. 2. Expression of human a2 and a5 subunits in NIH3T3
cells. NIH3T3 cells were transfected with constructs expressing either
the human a2 (Hua2) or human a5 receptor (Hua5). Cells expressing
exogenous integrin subunits were selected and expanded as described
under “Experimental Procedures.” A, human a2 and a5 subunits were
immunoprecipitated (IP) from Hua2-NIH3T3 and Hua5-NIH3T3 cell
lysates with P1E6 or P1D6 antibodies, respectively. Immunoprecipi-
tates were analyzed by Western blotting (WB) with anti-a2 or anti-a5
antibodies. B, Hua2-NIH3T3 and Hua5-NIH3T3 were incubated with
P1E6 or P1D6 antibodies. Antibody staining was analyzed by incubat-
ing with secondary antibody coupled to phycoerythrin and measured on
a flow cytometer. The ordinate displays cell number, and the abscissa
shows the relative fluorescence intensity on an arbitrary scale.
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MAP kinase under each condition (Fig. 3C). Hua2-NIH3T3
plated on anti-a2 and Hua5-NIH3T3 adhering to anti-a5 gave
2.5- and 2.9-fold enhanced activation over cells treated with
EGF in suspension, respectively (Fig. 3C). The comparable
signaling when cells are attached via either a2b1 or a5b1 inte-
grins again indicates a lack of a chain specificity in adhesion-
dependent growth factor signaling.
Next we performed experiments designed to provide insight
into the mechanistic details of integrin-dependent signaling
provided by anchorage to these function-blocking antibodies.
We correlated our findings with the effects on two proteins that
have been implicated in integrin-mediated signal transduction,
FAK and Shc. FAK was immunoprecipitated from HUVECs
that were plated on anti-a2, anti-a5, or fibronectin for 2 h or
maintained in suspension and then in some cases stimulated
with EGF. FAK was highly phosphorylated to equivalent levels
in HUVECs plated on anti-a2, anti-a5, or fibronectin but not in
cells maintained in suspension (Fig. 4A). EGF treatment did
not alter FAK tyrosine phosphorylation levels. Additionally,
FAK was immunoprecipitated from Hua2-NIH3T3 and Hua5-
NIH3T3 cell lysates that were plated on anti-a2, anti-a5, or
fibronectin or maintained in suspension. FAK was highly phos-
phorylated on tyrosine residues when either Hua2-NIH3T3 or
Hua5-NIH3T3 cells adhered to fibronectin but not when cells
were maintained in suspension (Fig. 4B). However, the tyro-
sine phosphorylation of FAK was reduced when cells were
plated on antibody-coated surfaces, compared with fibronectin,
consistent with the lesser degree of spreading observed. We
have previously shown that EGF stimulation of NIH3T3 does
not affect the tyrosine phosphorylation state of FAK (21). These
observations indicate that the degree of FAK tyrosine phospho-
rylation correlates with the level of collaboration between in-
tegrins and growth factors in the signaling to MAP kinases.
The SH2-PTB domain containing adaptor protein, Shc, was
analyzed from Hua2-NIH3T3 and Hua5-NIH3T3 cell lines un-
der our assay conditions. NIH3T3 cells contain the 46-, 52-, and
66-kDa forms of Shc, although the 52-kDa form is predominant
(Fig. 5, lower panel). Shc was weakly phosphorylated on tyro-
sine residues when immunoprecipitated from cells that were
adherent to anti-integrin antibodies or fibronectin, or main-
tained in suspension in serum-free conditions, in both Hua2-
NIH3T3 or Hua5-NIH3T3 (Fig. 5). However, Shc was robustly
phosphorylated on tyrosine residues upon EGF treatment. Fur-
ther experiments indicated that Shc was highly tyrosine-phos-
phorylated in response to EGF treatment of Hua2-NIH3T3 or
Hua5-NIH3T3 on anti-a2 and anti-a5, respectively (data not
shown). These findings indicate that Shc does not play a role in
the integrin-mediated events that lead to collaborative effects
FIG. 3. Anchorage-dependent growth factor signaling to MAP
kinases in NIH3T3 cells is a subunit-independent. Serum-starved
Hua2-NIH3T3 (A) and Hua5-NIH3T3 (B) cell lines were detached and
incubated non-adherently for 45 min at 37 °C. Cells were allowed to
adhere to fibronectin (Fn) or anti-human a2 or a5 antibody (a2 or
a5)-coated plates or maintained in suspension (Sus) for 2 h in serum-
free conditions before treatment with the indicated concentrations of
EGF for 5 min. Cells were lysed in modified RIPA buffer and analyzed
by Western blotting (WB) with antibodies to active MAP kinases and
total levels of MAP kinases. C, bands from Western blots from active
and total MAP kinase were quantified using a GS-670 model densitom-
eter. Immunoreactivity for active MAP kinase was normalized for the
amount of total MAP kinase for each condition and expressed as a value
relative to the value for EGF stimulation in fibronectin adherent cells.
Shown is the average and standard deviation from four separate exper-
iments. The enhanced MAP kinase activity in EGF-treated cells adher-
ent to anti-a chain antibodies over cells stimulated in suspension is
statistically significant (*p , 0.05) in both Hua2-NIH3T3 and Hua5-
NIH3T3 cell lines.
FIG. 4. Anchorage-dependent signaling to MAP kinase corre-
lates with the degree of tyrosine phosphorylation of FAK. Se-
rum-starved HUVECs (A) or Hua2-NIH3T3 and Hua5-NIH3T3 cell
lines (B) were allowed to either adhere to anti-human a2 or a5 antibody
(a2 or a5)-coated plates or fibronectin (Fn) or maintained in suspension
(Sus) for 2 h. Cells were lysed in modified RIPA buffer, and FAK was
immunoprecipitated (IP) using the C-terminal antibody, clone 2A7.
Immunoprecipitated proteins were separated on 8% SDS-PAGE gels
and analyzed by Western blotting (WB) with the N-terminal FAK an-
tibody, clone 77. PY, tyrosine phosphorylation.
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with the MAP kinase cascade but instead is activated solely by
growth factor actions.
DISCUSSION
We show that engagement of specific integrin a chains does
not determine the ability of fibroblasts or endothelial cells to
activate MAP kinase in response to epidermal growth factor
treatment. Rather we find that permissive signaling to MAP
kinases is more dependent upon the degree of cytoskeletal
architecture rather that the specific integrins employed. Thus,
tyrosine phosphorylation of FAK, a correlate of the degree of
actin organization, serves as a good indicator of the ability of
cells to respond to EGF. In our system, it appears that Shc does
not play a role in the integrin-mediated events that converge
with the growth factor-triggered MAP kinase pathway.
These findings indicate that different mechanisms are em-
ployed to activate MAP kinase in collaborative signaling when
cells are treated with growth factors after having spread and
formed new focal contacts, as compared with signaling directly
initiated by adherence. Our analysis of collaborative signaling
indicates a role for FAK in this process. FAK has a number of
binding partners, such as Src, phosphatidylinostol-3-kinase,
and p130Cas, that may mediate such an effect. We have yet to
determine unequivocally whether FAK plays an active role in
this process or is rather simply a marker of the extent of this
process. In contrast, MAP kinase can be directly activated by
integrins in the absence of FAK tyrosine phosphorylation (19,
22). However, it should be noted that overexpression of FAK is
able to enhance direct signaling to MAP kinase (30). A natu-
rally occurring regulator of FAK function, FAK-related non-
kinase, is expressed is some cell types (31). FAK-related non-
kinase contains the C-terminal focal adhesion targeting
sequence of FAK and is thought to compete for FAK-binding
sites in focal adhesions (32). Expression of FAK-related non-
kinase in our assay had no effect on the growth factor activa-
tion of extracellular signal-regulated kinase-MAP kinases
(data not shown). This result is not unexpected since FAK-
related non-kinase inhibition of FAK function and cell spread-
ing is transient, and the transfected cells are spreading after
2 h of adhesion to fibronectin.
Our data indicate the adaptor protein, Shc, is not involved in
the process that makes growth factor signaling more efficient
in integrin-anchored cells. In our system, Shc is not tyrosine-
phosphorylated at the 2-h time point when we stimulate the
cells with growth factor. It is important to note here that at this
time point, direct-mediated adhesion MAP kinase activation
has dissipated. Some previous studies have shown that Shc
becomes transiently phosphorylated on tyrosine residues upon
engagement of a5, av, and a1 integrin complexes (19, 33). In
contrast, others (34, 35) have recently shown that Shc tyrosine
phosphorylation levels are unaltered upon fibroblast or smooth
muscle cell adhesion to fibronectin under experimental condi-
tions whereby MAP kinase is activated. Our findings do not
speak to the issue of direct integrin-mediated phosphorylation
of Shc but rather suggest a lack of a role for Shc in the integrin
events that collaborate with growth factor signaling to activate
MAP kinase.
One common theme between the direct signaling and the
co-signaling effects is the importance of the role of the actin
cytoskeleton (4, 6, 8). In HUVECs, which spread comparably on
antibody-coated surfaces and fibronectin, growth factor signal-
ing to MAP kinases was similar under both conditions. In
contrast, NIH3T3 cell lines failed to spread extensively on
antibody-coated surfaces and thus exhibited reduced signaling
in comparison to fibronectin-adherent cells, although signaling
was enhanced over signaling in suspension. Cytochalasin D
treatment of cells, causing actin depolymerization, can block
both direct and collaborative signaling to MAP kinase (4, 6, 8).
Due to the inefficient spreading the human a chain overex-
pressing NIH3T3 cell lines on the antibody-coated surfaces,
these cells were not particularly suitable for studying direct-
mediated signaling to MAP kinase.
The influence that anchorage-dependent regulation of
growth factor signaling to MAP kinase exerts on cell cycle
components has not been established. However, recent evi-
dence from two separate groups indicates that MAP kinase
activity may be necessary, but not sufficient, to permit cell
cycle progression (23, 24). Thus, it seems possible that the
observed a chain-specific effects on cell growth (19, 20) proba-
bly involve aspects of cell cycle regulation other than activation
of the Raf-MAP kinase pathway. Future experiments will be
directed to determine the necessary structural regions of inte-
grin receptors for co-signaling to occur and to address directly
the importance of efficient activation of MAP kinases to down-
stream events, such as cell cycle progression. These studies will
further elucidate both mechanistic details and the biological
importance of adhesion via integrin receptors to critical cellular
events.
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